Medium Biosciences
AI-designed Protein Therapeutics
San Francisco, United States · Founded 2021
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Website
- medium.bio
- Last Round
- SeedMar 2021
- Rounds
- 1
About
We develop AI models & new assays to create functional, therapeutic proteins.
Summary
Medium Biosciences is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. Its most recent funding was a Seed round in Mar 2021. Investors include E14 Fund, AIX Ventures and Village Global.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2021
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/medium-biosciences"><img src="https://indexed.vc/api/badge/company/medium-biosciences" alt="Medium Biosciences on Indexed.vc" width="260" height="76" /></a>